{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:48:57Z","timestamp":1792550937958,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.molimm.2009.05.178","type":"journal-article","created":{"date-parts":[[2009,6,22]],"date-time":"2009-06-22T05:20:31Z","timestamp":1245648031000},"page":"2441-2448","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["TRAF1 is involved in the classical NF-\u03baB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells"],"prefix":"10.1016","volume":"46","author":[{"given":"Feng","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aining","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianquan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2009.05.178_bib1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.coph.2004.02.007","article-title":"The role of CD30 in the pathogenesis of haematopoietic malignancies","volume":"4","author":"Al-Shamkhani","year":"2004","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.molimm.2009.05.178_bib2","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1038\/sj.onc.1202568","article-title":"Modulation of life and death by the TNF receptor superfamily","volume":"17","author":"Baker","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.molimm.2009.05.178_bib3","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1172\/JCI119849","article-title":"Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells","volume":"100","author":"Bargou","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molimm.2009.05.178_bib4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/978-0-387-70630-6_11","article-title":"TRAF proteins in CD40 signaling","volume":"597","author":"Bishop","year":"2007","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.molimm.2009.05.178_bib5","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1006\/bbrc.1997.6509","article-title":"Binding sites of cytoplasmic effectors TRAF1, 2, and 3 on CD30 and other members of the TNF receptor superfamily","volume":"28","author":"Boucher","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molimm.2009.05.178_bib6","doi-asserted-by":"crossref","first-page":"6482","DOI":"10.1038\/sj.onc.1204788","article-title":"Tumor necrosis factor receptor-associated factors (TRAFs)","volume":"20","author":"Bradley","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.molimm.2009.05.178_bib7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/978-0-387-70630-6_12","article-title":"TRAFs in RANK signaling","volume":"597","author":"Darnay","year":"2007","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.molimm.2009.05.178_bib8","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1101\/gad.11.21.2810","article-title":"CD30-dependent degradation of TRAF2: implications for negative regulation of TRAF signaling and the control of cell survival","volume":"11","author":"Duckett","year":"1997","journal-title":"Genes Dev."},{"key":"10.1016\/j.molimm.2009.05.178_bib9","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0092-8674(92)90180-K","article-title":"Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease","volume":"68","author":"D\u00fcrkop","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.molimm.2009.05.178_bib10","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1182\/blood.V93.2.617","article-title":"Tumor necrosis factor receptor-associated factor 1 is overexpressed in Reed\u2013Sternberg cells of Hodgkin's disease and Epstein-Barr virus-transformed lymphoid cells","volume":"93","author":"D\u00fcrkop","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2009.05.178_bib11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/path.1351","article-title":"Differential expression and function of A20 and TRAF1 in Hodgkin lymphoma and anaplastic large cell lymphoma and their induction by CD30 stimulation","volume":"200","author":"D\u00fcrkop","year":"2003","journal-title":"J. Pathol."},{"key":"10.1016\/j.molimm.2009.05.178_bib12","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1365-2141.1995.tb08415.x","article-title":"Mediastinal large B-cell lymphoma: clinical and immunohistological findings in 18 patients treated with different third-generation regimens","volume":"89","author":"Falini","year":"1995","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.molimm.2009.05.178_bib13","doi-asserted-by":"crossref","first-page":"34120","DOI":"10.1074\/jbc.273.51.34120","article-title":"The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-kappaB, a member of the TNFR superfamily","volume":"273","author":"Galibert","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molimm.2009.05.178_bib14","doi-asserted-by":"crossref","first-page":"12852","DOI":"10.1074\/jbc.271.22.12852","article-title":"CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins","volume":"271","author":"Gedrich","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molimm.2009.05.178_bib15","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0950-3536(96)80019-9","article-title":"Pathophysiology of Hodgkin's disease: functional and molecular aspects","volume":"9","author":"Gruss","year":"1996","journal-title":"Baillieres Clin. Haematol."},{"key":"10.1016\/j.molimm.2009.05.178_bib16","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1182\/blood-2007-02-075143","article-title":"Constitutive alternative NF-kappaB signaling promotes marginal zone B-cell development but disrupts the marginal sinus and induces HEV-like structures in the spleen","volume":"110","author":"Guo","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2009.05.178_bib17","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1182\/blood-2007-11-125930","article-title":"Lack of nuclear factor-kappa B2\/p100 causes a RelB-dependent block in early B lymphopoiesis","volume":"112","author":"Guo","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2009.05.178_bib18","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.4049\/jimmunol.165.3.1322","article-title":"TNF receptor family member BCMA (B cell maturation) associates with TNF receptor-associated factor (TRAF) 1, TRAF2, and TRAF3 and activates NF-kappa B, elk-1, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase","volume":"165","author":"Hatzoglou","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2009.05.178_bib19","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1084\/jem.20061166","article-title":"Rescue of TRAF3-null mice by p100 NF-kappa B deficiency","volume":"203","author":"He","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molimm.2009.05.178_bib20","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1182\/blood.V97.9.2798","article-title":"Constitutive NF-kappaB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin\/Reed\u2013Sternberg cells","volume":"97","author":"Hinz","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2009.05.178_bib21","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2353\/ajpath.2008.070858","article-title":"CD30-induced signaling is absent in Hodgkin's cells but present in anaplastic large cell lymphoma cells","volume":"172","author":"Hirsch","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.molimm.2009.05.178_bib22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/intimm\/10.2.203","article-title":"A novel domain in the CD30 cytoplasmic tail mediates NFkappaB activation","volume":"10","author":"Horie","year":"1998","journal-title":"Int. Immunol."},{"key":"10.1016\/j.molimm.2009.05.178_bib23","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1006\/smim.1998.0156","article-title":"CD30: expression and function in health and disease","volume":"10","author":"Horie","year":"1998","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.molimm.2009.05.178_bib24","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1038\/sj.onc.1205337","article-title":"Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin\u2013Reed\u2013Sternberg cells","volume":"11","author":"Horie","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.molimm.2009.05.178_bib25","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1358\/dnp.2003.16.10.829295","article-title":"The biological basis of Hodgkin's lymphoma","volume":"16","author":"Horie","year":"2003","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.molimm.2009.05.178_bib26","doi-asserted-by":"crossref","first-page":"11085","DOI":"10.1073\/pnas.93.20.11085","article-title":"Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein","volume":"93","author":"Kaye","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molimm.2009.05.178_bib27","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/modpathol.3880243","article-title":"Expression of the tumor necrosis factor receptor-associated factors (TRAFs) 1 and 2 is a characteristic feature of Hodgkin and Reed\u2013Sternberg cells","volume":"13","author":"Izban","year":"2000","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.molimm.2009.05.178_bib28","doi-asserted-by":"crossref","first-page":"9699","DOI":"10.1073\/pnas.93.18.9699","article-title":"CD30\/TNF receptor-associated factor interaction: NF-kappaB activation and binding specificity","volume":"93","author":"Lee","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molimm.2009.05.178_bib29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-0-387-70630-6_2","article-title":"TRAF1 and its biological functions","volume":"597","author":"Lee","year":"2007","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.molimm.2009.05.178_bib30","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1182\/blood.V95.4.1443.004k55_1443_1450","article-title":"Hodgkin and Reed\u2013Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription","volume":"95","author":"Marafioti","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2009.05.178_bib31","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1182\/blood.V100.10.3749","article-title":"Tumor necrosis factor receptor-associated factor 1 gene overexpression in B-cell chronic lymphocytic leukemia: analysis of NF-kappa B\/Rel-regulated inhibitors of apoptosis","volume":"15","author":"Munzert","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2009.05.178_bib32","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1038\/sj.onc.1208564","article-title":"Aberrant NF-kappaB2\/p52 expression in Hodgkin\/Reed\u2013Sternberg cells and CD30-transformed rat fibroblasts","volume":"24","author":"Nonaka","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.molimm.2009.05.178_bib33","doi-asserted-by":"crossref","first-page":"11836","DOI":"10.1021\/bi981067q","article-title":"CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization","volume":"37","author":"Pullen","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.molimm.2009.05.178_bib34","doi-asserted-by":"crossref","first-page":"5118","DOI":"10.1182\/blood-2007-09-110635","article-title":"Overexpressed NF-kappaB-inducing kinase contributes to the tumorigenesis of adult T-cell leukemia and Hodgkin Reed\u2013Sternberg cells","volume":"111","author":"Saitoh","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2009.05.178_bib35","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1385\/IR:27:2-3:499","article-title":"Death receptor signaling and autoimmunity","volume":"27","author":"Siegel","year":"2003","journal-title":"Immunol. Res."},{"key":"10.1016\/j.molimm.2009.05.178_bib36","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1084\/jem.185.10.1777","article-title":"A regulatory role for TRAF1 in antigen-induced apoptosis of T cells","volume":"185","author":"Speiser","year":"1997","journal-title":"J Exp Med."},{"key":"10.1016\/j.molimm.2009.05.178_bib37","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1034\/j.1600-065X.2003.00064.x","article-title":"Regulation of secondary lymphoid organ development by the nuclear factor-kappaB signal transduction pathway","volume":"195","author":"Weih","year":"2003","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.molimm.2009.05.178_bib38","doi-asserted-by":"crossref","first-page":"28355","DOI":"10.1074\/jbc.273.43.28355","article-title":"The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor","volume":"273","author":"Wong","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molimm.2009.05.178_bib39","doi-asserted-by":"crossref","first-page":"10252","DOI":"10.1074\/jbc.M608817200","article-title":"CD30 activates both the canonical and alternative NF-kappaB pathways in anaplastic large cell lymphoma cells","volume":"6","author":"Wright","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molimm.2009.05.178_bib40","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.4049\/jimmunol.173.9.5546","article-title":"Roles of TNF receptor-associated factor 3 in signaling to B lymphocytes by carboxyl-terminal activating regions 1 and 2 of the EBV-encoded oncoprotein latent membrane protein 1","volume":"173","author":"Xie","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2009.05.178_bib41","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/emboj\/cdg004","article-title":"RelB is required for Peyer's patch development: differential regulation of p52\u2013RelB by lymphotoxin and TNF","volume":"22","author":"Yilmaz","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.molimm.2009.05.178_bib42","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.4049\/jimmunol.165.9.5084","article-title":"TNFR-associated factor family protein expression in normal tissues and lymphoid malignancies","volume":"165","author":"Zapata","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2009.05.178_bib43","doi-asserted-by":"crossref","first-page":"16600","DOI":"10.1073\/pnas.0407541101","article-title":"TNF receptor-associated factor (TRAF) domain and Bcl-2 cooperate to induce small B cell lymphoma\/chronic lymphocytic leukemia in transgenic mice","volume":"101","author":"Zapata","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molimm.2009.05.178_bib44","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1182\/blood-2002-11-3507","article-title":"MEK\/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival","volume":"102","author":"Zheng","year":"2003","journal-title":"Blood"}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589009002454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589009002454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:22:48Z","timestamp":1758979368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589009002454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":44,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0161589009002454"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2009.05.178","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TRAF1 is involved in the classical NF-\u03baB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2009.05.178","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}